三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
RBANS总分变化比较:完成者vS.ITT-MAR(p=0.032VS.0.012;调整β=4.75VS.4.67)
RBANS总分变化比较:完成者vS.ITT-MAR(p=0.032VS.0.012;调整β=4.75VS.4.67)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:60KB
图片尺寸:1383*801
同报告图片
/
4
fCDliIbmnpDnsbvlnosgICAgICAgICB8IE4gICB8IEVHNTAx5Z2H5YC8zpQgfCDlronmhbDliYLlnYflgLzOlCB8CnwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18Cnwg5a6M5oiQ6ICF5YiG5p6QICAgICAgIHwgNDMgIHwgMTAuNSAgICAgICB8IDQuMyAgICAgICAgIHwKfCBJVFQgLSBNQVLliIbmnpAgICAgfCA1NiAgfCAxMC40ICAgICAgIHwgNC40ICAgICAgICAgfAoK5pWw5o2u5p2l5rqQ77ya5Z+D5qC85p6X5Yy76I2v5L6b5Zu+
fCDnsbvliKsgICAgICAgICAgIHwg5Y2g5q+UIHwKfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tfAp8IOWPjOaKl0FEQyAgICAgICAgfCA1MSUgIHwKfCBBT0MgICAgICAgICAgICB8IDE1JSAgfAp8IERBQyAgICAgICAgICAgIHwgMTAlICB8Cnwg5oqX5L2T54mH5q615YG257uD54mpIHwgOCUgICB8Cnwg5Y+M6L296I23QURDICAgICAgfCAxMyUgIHwKfCDlj4zovb3ojbflj4zmipdBREMgIHwgMyUgICB8CgrotYTmlpnmnaXmupDvvJrkuJzlkLTor4HliLjjgIHoja/mmI7lurflvrc=
fCDliIbmnpDnsbvlnosgICAgICAgICB8IE4gICB8IEVHNTAx5Z2H5YC8zpQgfCDlronmhbDliYLlnYflgLzOlCB8CnwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18Cnwg5a6M5oiQ6ICF5YiG5p6QICAgICAgIHwgNDMgIHwgMTAuNSAgICAgICB8IDQuMyAgICAgICAgIHwKfCBJVFQgLSBNQVLliIbmnpAgICAgfCA1NiAgfCAxMC40ICAgICAgIHwgNC40ICAgICAgICAgfAoK5pWw5o2u5p2l5rqQ77ya5Z+D5qC85p6X5Yy76I2v5L6b5Zu+
所属报告:
动脉智库:2025创新药及供应链年度创新白皮书:分化加速行业回归平台与产品价值(90页).pdf
打包全文图表
相关数据
多纳非尼ZGDD3临床研究无进展生存期数据(ITT集)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
多纳非尼ZGDD3临床研究有效性数据(ITT集)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
Water Transportation: Median Revenue Multiples (Mar 2023 – Jun 2024)
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
收藏
行业数据
2026-04-22
原图定位
查看详情
Finnair Monthly Traffic (Oct 2025 – Mar 2026)
收藏
行业数据
2026-04-22
原图定位
查看详情
ASUR Total Traffic Year-over-Year Change (Jan 2024 – Mar 2026)
收藏
行业数据
2026-04-22
原图定位
查看详情
Exhibit 129: MPl's foreign holdings and share price (Jan 2025–Mar 2026)
收藏
行业数据
2026-04-22
原图定位
查看详情
CPI % and Fed Funds Rate Trend (Mar-24 to Feb-26)
收藏
行业数据
2026-04-20
原图定位
查看详情
CARTITUDE-4: Overall MRD Negativity in Subgroups (ITT)
IyMjIOaVsOaNruihqOagvAoKfCBTdWJncm91cCBDYXRlZ29yeSAgICAgICAgICB8IFN1Ymdyb3VwICAgICAgICAgICAgICAgICAgICAgICAgICB8IE9kZHMgUmF0aW8gKDk1JSBDSSkgICAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgQWdlICAgICAgICAgICAgICAgICAgICAgICAgfCA8NjUgeWVhcnMgICAgICAgICAgICAgICAgICAgICAgICAgfCA3Ljc5ICg0LjM14oCTMTMuOTMpICAgICAgICAgfAp8IEFnZSAgICAgICAgICAgICAgICAgICAgICAgIHwgNjXigJM3NSB5ZWFycyAgICAgICAgICAgICAgICAgICAgICAgfCA1Ljg2ICgyLjg54oCTMTEuOTEpICAgICAgICAgfAp8IE51bWJlciBvZiBsaW5lcyBvZiBwcmlvciB0aGVyYXB5IHwgMSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNi40OCAoMy4wM+KAkzEzLjg0KSAgICAgICAgIHwKfCBOdW1iZXIgb2YgbGluZXMgb2YgcHJpb3IgdGhlcmFweSB8IDIgb3IgMyAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDcuNjYgKDQuNDDigJMxMy4zNCkgICAgICAgICB8CnwgSVNTIHN0YWdpbmcgICAgICAgICAgICAgICAgfCBJICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCA2LjkwICgzLjk54oCTMTEuOTYpICAgICAgICAgfAp8IElTUyBzdGFnaW5nICAgICAgICAgICAgICAgIHwgSUkgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNy4xOSAoMy4wOeKAkzE2Ljc1KSAgICAgICAgIHwKfCBJU1Mgc3RhZ2luZyAgICAgICAgICAgICAgICB8IElJSSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDEyLjAwICgxLjc24oCTODEuNzQpICAgICAgICB8CnwgUHJlc2VuY2Ugb2Ygc29mdCB0aXNzdWUgcGxhc21hY3l0b21hcyB8IFllcyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMi41MiAoMC45MOKAkzcuMDMpICAgICAgICAgIHwKfCBQcmVzZW5jZSBvZiBzb2Z0IHRpc3N1ZSBwbGFzbWFjeXRvbWFzIHwgTm8gICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCA5LjY5ICg1Ljg14oCTMTYuMDYpICAgICAgICAgfAp8IFR1bW9yIGJ1cmRlbiAgICAgICAgICAgICAgIHwgTG93ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNy4wMSAoMy45NOKAkzEyLjQ1KSAgICAgICAgIHwKfCBUdW1vciBidXJkZW4gICAgICAgICAgICAgICB8IEludGVybWVkaWF0ZSAgICAgICAgICAgICAgICAgICAgICB8IDUuMTMgKDIuMjLigJMxMS44NSkgICAgICAgICB8CnwgVHVtb3IgYnVyZGVuICAgICAgICAgICAgICAgfCBIaWdoICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAyNC4xMCAoNC45MeKAkzEyMS42MykgICAgICAgfAp8IEN5dG9nZW5ldGljIHJpc2sgYXQgc3R1ZHkgZW50cnkgfCBIaWdoIHJpc2sgICAgICAgICAgICAgICAgICAgICAgICAgfCAxMi43NyAoNi45NuKAkzIzLjQ0KSAgICAgICAgfAp8IEN5dG9nZW5ldGljIHJpc2sgYXQgc3R1ZHkgZW50cnkgfCBTdGFuZGFyZCByaXNrICAgICAgICAgICAgICAgICAgICAgfCAzLjQwICgxLjY14oCTNy4wMCkgICAgICAgICAgfAp8IFJlZnJhY3RvcnkgdG8gICAgICAgICAgICAgIHwgUEkgKyBJTWlEICAgICAgICAgICAgICAgICAgICAgICAgIHwgOC41MSAoNC4zMeKAkzE2Ljc2KSAgICAgICAgIHwKfCBSZWZyYWN0b3J5IHRvICAgICAgICAgICAgICB8IEFudGktQ0QzOCArIElNaUQgICAgICAgICAgICAgICAgICB8IDEzLjIzICgzLjYy4oCTNDguMzIpICAgICAgICB8CnwgUmVmcmFjdG9yeSB0byAgICAgICAgICAgICAgfCBQSSArIGFudGktQ0QzOCArIElNaUQgICAgICAgICAgICAgfCAxMS44NSAoMi4zOeKAkzU4LjgyKSAgICAgICAgfAp8IFJlZnJhY3RvcnkgdG8gICAgICAgICAgICAgIHwgTGFzdCBsaW5lIG9mIHByaW9yIHRoZXJhcHkgICAgICAgIHwgNy40NCAoNC43NOKAkzExLjY4KSAgICAgICAgIHwKfCBQcmlvciBleHBvc3VyZSB0byAgICAgICAgICB8IERhcmF0dW11bWFiICAgICAgICAgICAgICAgICAgICAgICB8IDI1LjAwICg1LjQ54oCTMTEzLjc3KSAgICAgICB8CnwgUHJpb3IgZXhwb3N1cmUgdG8gICAgICAgICAgfCBCb3J0ZXpvbWliICAgICAgICAgICAgICAgICAgICAgICAgfCA3LjE5ICg0LjU44oCTMTEuMzApICAgICAgICAgfAp8IFByaW9yIGV4cG9zdXJlIHRvICAgICAgICAgIHwgQm9ydGV6b21pYiBhbmQgZGFyYXR1bXVtYWIgICAgICAgIHwgMjIuMDggKDQuNjHigJMxMDEuMzIpICAgICAgIHwKfCBQcmlvciBleHBvc3VyZSB0byAgICAgICAgICB8IERhcmEgbmHDr3ZlICAgICAgICAgICAgICAgICAgICAgICAgfCA2LjM2ICgzLjg44oCTMTAuNDQpICAgICAgICAgfAoKCiMjIyDotYTmlpnmnaXmupAgIApQcmVzZW50ZWQgYnkgUiBQb3BhdCBhdCB0aGUgNjZ0aCBBbWVyaWNhbiBTb2NpZXR5IG9mIEhlbWF0b2xvZ3kgKEFTSCkgQW5udWFsIE1lZXRpbmc7IERlY2VtYmVyIDfigJMxMCwgMjAyNDsgU2FuIERpZWdvLCBDQSwgVVNB
收藏
行业数据
2026-03-11
原图定位
查看详情
CARTITUDE-4: Secondary Endpoint (ITT) – Response
IyMjIENBUlRJVFVERS00OiBTZWNvbmRhcnkgRW5kcG9pbnQgKElUVCkg4oCTIFJlc3BvbnNlIERhdGEKCiMjIyMgT3ZlcmFsbCBSZXNwb25zZSBSYXRlIChPUlIpIGJ5IFJlc3BvbnNlIENhdGVnb3J5CnwgUmVzcG9uc2UgQ2F0ZWdvcnkgfCBDaWx0YS1jZWwgKElUVCwgTj0yMDgpIHwgU09DIChJVFQsIE49MjExKSB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18Cnwgc0NSICAgICAgICAgICAgICAgfCAxNC45JSAgICAgICAgICAgICAgICAgIHwgNi42JSAgICAgICAgICAgICB8CnwgQ1IgICAgICAgICAgICAgICAgfCA1OC4yJSAgICAgICAgICAgICAgICAgIHwgMTUuMiUgICAgICAgICAgICB8CnwgVkdQUiAgICAgICAgICAgICAgfCA4LjIlICAgICAgICAgICAgICAgICAgIHwgMjMuNyUgICAgICAgICAgICB8CnwgUFIgICAgICAgICAgICAgICAgfCAzLjQlICAgICAgICAgICAgICAgICAgIHwgMjEuOCUgICAgICAgICAgICB8CnwgKipPUlIqKiAgICAgICAgICAgfCAqKjg0LjYlICgxNzYvMjA4KSoqICAgIHwgKio2Ny4zJSAoMTQyLzIxMSkqKiB8CgojIyMjIEtleSBTZWNvbmRhcnkgRW5kcG9pbnRzCnwgRW5kcG9pbnQgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCBDaWx0YS1jZWwgKElUVCwgTj0yMDgpICAgICAgIHwgU09DIChJVFQsIE49MjExKSAgICAgICAgICAgICB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IE9kZHMgUmF0aW8gZm9yIE9SUiAgICAgICAgICAgICAgICAgICAgICAgIHwgMy4wICgxLjjigJM1LjApLCBQPDAuMDAwMSAgICAgIHwg4oCUICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMTItbW9udGggRE9SIHJhdGUsICUgKDk1JSBDSSkgICAgICAgICAgICAgfCA4NC43ICg3OC4x4oCTODkuNCkgICAgICAgICAgICAgfCA2My4wICg1NC4y4oCTNzAuNikgICAgICAgICAgICAgfAp8IER1cmF0aW9uIG9mIHJlc3BvbnNlLCBtb250aHMgbWVkaWFuICg5NSUgQ0kpIHwgTlIgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDE2LjYgKDEyLjnigJNORSkgICAgICAgICAgICAgICB8CgoKIyMjIOi1hOaWmeadpea6kCAgCipQcmVzZW50ZWQgYnkgRGhha2FsIGV0IGFsLiBhdCB0aGUgMjAyMyBBbWVyaWNhbiBTb2NpZXR5IG9mIENsaW5pY2FsIE9uY29sb2d5IChBU0NPKSBBbm51YWwgTWVldGluZzsgSnVuZSAyLTYs
收藏
行业数据
2026-03-11
原图定位
查看详情
ALPINE研究终期分析时研究者评估的PFS(ITT人群)
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
收藏
行业数据
2025-04-18
原图定位
查看详情
IMpower150研究:ITT人群总生存期(OS)KM曲线
fCBUcmVhdG1lbnQgYXJtIHwgTWVkaWFuIE9TIHwgSFIgKDk1JSBDSSkgfCBwLXZhbHVlIHwKfC0tLXwtLS18LS0tfC0tLXwKfCBUZWNlbnRyaXErYmV2YWNpenVtYWIrcGFjbGl0YXhlbCtjYXJib3BsYXRpbiB8IDE5LjggbW8gfCAwLjc2ICgwLjYzLCAwLjk2KSB8IDAuMDA2MCB8CnwgVGVjZW50cmlxK3BhY2xpdGF4ZWwrY2FyYm9wbGF0aW4gfCAxOS41IG1vIHwgMC44NSAoMC43MSwgMS4wMykgfCAwLjA5ODMgfAp8IEJldmFjaXp1bWFiK3BhY2xpdGF4ZWwrY2FyYm9wbGF0aW4gfCAxNC45IG1vIHwgIHwgIHwKCui1hOaWmeadpea6kO+8muWfuuefs+iNr+S4muaOqOS7i+adkOaWme+8jOWkqemjjuivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-03-11
原图定位
查看详情
IMpower150研究:ITT人群无进展生存期(PFS)KM曲
fCBUcmVhdG1lbnQgYXJtIHwgTWVkaWFuIFBGUyB8IEhSICg5NSUgQ0kpIHwgcC12YWx1ZSB8CnwtLS18LS0tfC0tLXwtLS18CnwgVGVjZW50cmlxK2JldmFjaXp1bWFiK3BhY2xpdGF4ZWwrY2FyYm9wbGF0aW4gfCA4LjQgbW8gfCAwLjU5ICgwLjUwLCAwLjY5KSB8ICZsdDsgMC4wMDAxIHwKfCBUZWNlbnRyaXErcGFjbGl0YXhlbCtjYXJib3BsYXRpbiB8IDYuNyBtbyB8IDAuOTEgKDAuNzgsIDEuMDYpIHwgMC4yMTk0IHwKfCBCZXZhY2l6dW1hYitwYWNsaXRheGVsK2NhcmJvcGxhdGluIHwgNi44IG1vIHwgIHwgIHwKCui1hOaWmeadpea6kO+8muWfuuefs+iNr+S4muaOqOS7i+adkOaWme+8jOWkqemjjuivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-03-11
原图定位
查看详情
ITT人群PFS亚组分析(IRC评估)
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
收藏
行业数据
2025-02-10
原图定位
查看详情
IMpower150:疗效和安全性(ITT人群)
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
收藏
行业数据
2024-12-20
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
AI赋能川I期策略,加速推进上市进程 EG-501选择40mg/天的剂量,旨在克服神经炎症环境下血脑屏障渗透率下降的 挑战,确保药物在中枢神经系统达到有效靶点浓度。ⅡI期研究结果也证实,该剂 量下患者用药依从性高,具备长期治疗的可行性。 目前,EG-501项目已进入川期临床准备阶段。下一步研究将采用生物利用度更 优的制剂,计划纳入约 260 例患者,并将治疗周期延长至 24 周,以充分评估其 慢性神经保护效应。川I期试验将采用认知应答率与患者报告结局作为共同主要终 寻求突破性疗法认定,加速药物上市进程。 EG-501的进展不仅验证了埃格林医药 AI研发平台的端到端能力,更有望为自身 免疫性疾病相关的认知障碍提供首个能够突破血脑屏障的靶向治疗选择。基于其 独特的作用机制,该药物未来还具备拓展至多发性硬化、类风湿关节炎相关认知 障碍、“化疗脑"等更广泛神经炎症适应症的潜力。
行业数据
原图定位
当前图表所属:
动脉智库:2025创新药及供应链年度创新白皮书:分化加速行业回归平台与产品价值(90页).pdf
图表57全球新型ADC细分类别
图表56技术趋势总览
按公司名首字母排序
RBANS总分变化比较:完成者vS.ITT-MAR(p=0.032VS.0.012;调整β=4.75VS.4.67)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》